Quick Answer
Beam Therapeutics Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $139.74 million for the year ending 2025.
- Beam Therapeutics Inc. showed an increase of +120.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Beam Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Beam Therapeutics Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 776,250.0%.
- Historical annual values: Fiscal year 2025: $139.74 million | Fiscal year 2024: $63.52 million | Fiscal year 2023: $377.71 million | Fiscal year 2022: $60.92 million | Fiscal year 2021: $51.84 million | Fiscal year 2020: $24.0 thousand | Fiscal year 2019: $18.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: